JAK inhibitors: beyond spleen and symptoms?

Haematologica. 2013 Feb;98(2):160-2. doi: 10.3324/haematol.2012.083543.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Humans
  • Janus Kinases / antagonists & inhibitors*
  • Primary Myelofibrosis / drug therapy*
  • Protein Kinase Inhibitors / pharmacology*
  • Protein Kinase Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • Janus Kinases